NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









AtaCor Medical

AtaCor Medical

Private
San Clemente, CaliforniaHealthcare & Life Scienceshttps://atacor.com/

Last Round

Financing

Oct 6, 2025

Est. Valuation

$80M

Total Funding Raised

$61.8M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

AtaCor Medical is a medical device company that develops extravascular cardiac pacing and defibrillation lead systems designed to provide alternatives to traditional transvenous devices.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

extravascular implantable cardioverter-defibrillatorEV-ICDcardiac rhythm managementimplantable defibrillatorleadless defibrillatorcardiac devicemedical device developmentclinical trialselectrophysiologypacing lead systemscardiologymedtechcardiac implant

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AtaCor Medical Comps

Public and private peers based on sector, stage, and business model.

AtaCor Medical comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

AtaCor Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
FinancingOct 6, 2025
Series CApr 24, 2024
Series BApr 28, 2020
Series ASep 18, 2018

Key People

Founding team and executive leadership

Rick Sanghera

CEO Co-Founder

Founding Team

Sean McGeehan

General Counsel CFO

Executive Team

AtaCor Medical Investors

Notable investors and investment history

AtaCor Medical investors
InvestorRounds
BayMed Venture PartnersSeries C, Financing
CHVSeries C, Series B
Arboretum VenturesFinancing, Series C
Hatteras Venture PartnersSeries B, Series C, Financing
aMoonSeries B, Series A
Longview PartnersSeries B
Catalyst Health VenturesSeries B, Series C, Financing

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 21, 2026

    Partnering with Abbott on investigational extravascular ICD system.

  • Oct 6, 2025

    $75M round raised

AtaCor Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AtaCor Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AtaCor Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Clemente, California
Employee Range33
Year Founded2014
Last FundingOct 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.